Consensus Shandong Boan Biotechnology Co., Ltd.

Equities

6955

CNE100005RV4

Delayed Hong Kong S.E. Other stock markets 03:48:32 06/06/2024 BST			5-day change	1st Jan Change
9 ^HKD	-4.05%		-3.43%	-41.94%

05-28	China Accepts Boan Biotechnology's Biologics License Application for Type 2 Diabetes Drug	MT
05-27	Shandong Boan Biotechnology Co., Ltd. Announces Acceptance of BLA in China for Dulaglutide Injection	CI

Evolution of the average Target Price on Shandong Boan Biotechnology Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

f75e7a715e911bbacdcbee83a79a.e6B0pFrD2JsJONBZL38POLuwL8BEBUuf72hiNn_C9IY.CM8EzhWu9cxdVqAhfkx_benJFoMmTgna2CMaeRmItv4alU3obKqgrT1X5A~8915882af4da9bd1c9e9c498d0ce7378

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

8.703 CNY

Average target price

10.44 CNY

Spread / Average Target

+19.96%

High Price Target

10.44 CNY

Spread / Highest target

+19.96%

Low Price Target

10.44 CNY

Spread / Lowest Target

+19.96%

Consensus detail

Consensus revision (last 18 months)

Ratings for Shandong Boan Biotechnology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar